VII4

David Faraoni1, Anna Guindi1, Ashish A Ankola2

  • 1Arthur S. Keats Division of Pediatric Cardiovascular Anesthesia, Department of Anesthesiology, Perioperative and Pain Medicine, Texas Children's Hospital, Baylor College of Medicine, Houston, TX.

概括

复合激活因子VII (rFVIIa) 在儿科心脏手术患者的血栓并发症的风险较高,与4因子前列红素复合物缩物 (4F-PCC) 相比. 这项研究发现,两种治疗方法之间的出血或输血率没有显著差异.